288 related articles for article (PubMed ID: 36982852)
1. Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids.
Yang Q; Al-Hendy A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982852
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation in Uterine Fibroids-The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application.
Włodarczyk M; Nowicka G; Ciebiera M; Ali M; Yang Q; Al-Hendy A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269864
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
4. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
Cao T; Jiang Y; Wang Z; Zhang N; Al-Hendy A; Mamillapalli R; Kallen AN; Kodaman P; Taylor HS; Li D; Huang Y
Oncogene; 2019 Jul; 38(27):5356-5366. PubMed ID: 31089260
[TBL] [Abstract][Full Text] [Related]
5. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract][Full Text] [Related]
6. The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth.
Tinelli A; Kosmas IP; Mynbaev OA; Malvasi A; Sparic R; Vergara D
Curr Pharm Des; 2020; 26(3):310-317. PubMed ID: 31987017
[TBL] [Abstract][Full Text] [Related]
7. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.
Yang Q; Ciebiera M; Bariani MV; Ali M; Elkafas H; Boyer TG; Al-Hendy A
Endocr Rev; 2022 Jul; 43(4):678-719. PubMed ID: 34741454
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Biol Reprod; 2013 Dec; 89(6):150. PubMed ID: 24174578
[TBL] [Abstract][Full Text] [Related]
10. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
11. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids.
Vergara D; Catherino WH; Trojano G; Tinelli A
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33670322
[TBL] [Abstract][Full Text] [Related]
13. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.
Mas A; Stone L; O'Connor PM; Yang Q; Kleven D; Simon C; Walker CL; Al-Hendy A
Stem Cells; 2017 Mar; 35(3):666-678. PubMed ID: 27739139
[TBL] [Abstract][Full Text] [Related]
14. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.
Ciebiera M; Włodarczyk M; Zgliczyńska M; Łukaszuk K; Męczekalski B; Kobierzycki C; Łoziński T; Jakiel G
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518097
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.
Lewis TD; Malik M; Britten J; San Pablo AM; Catherino WH
Biomed Res Int; 2018; 2018():2414609. PubMed ID: 29780819
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
[TBL] [Abstract][Full Text] [Related]
17. Uterine fibroids in menopause and perimenopause.
Ulin M; Ali M; Chaudhry ZT; Al-Hendy A; Yang Q
Menopause; 2020 Feb; 27(2):238-242. PubMed ID: 31834160
[TBL] [Abstract][Full Text] [Related]
18. Periostin's role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma.
Kiesler ZG; Hunter MI; Balboula AZ; Patterson AL
Arch Gynecol Obstet; 2024 May; 309(5):1825-1831. PubMed ID: 38441600
[TBL] [Abstract][Full Text] [Related]
19. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
20. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
